HLA-class I-specific inhibitory receptors in HIV-1 infection

Human Immunology

Volumn 61, Issue 1, 2000, Pages 74-81

  De Maria, Andrea ^a   Moretta, Lorenzo ^b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

CTL; HIV; KIR expression; NK receptors

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G; INTERLEUKIN 15; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0033984111     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00169-X     Document Type: Review

References (73)

1. Koenig S., Earl P., Powell D., Pantaleo G., Merli S., Moss B., Fauci A.S. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc Natl Acad Sci USA. 86:1988;8638.
2. Walker B.D., Flexner C., Paradis T.J., Fuller T.C., Hirsch M.S., Schooley R.T., Moss B. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science. 240:1988;64.
3. Hoffenbach A., Langlade-Demoyen P., Dadaglio G., Vilmer E., Michel F., Mayaud C., Autran B., Plata F. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 142:1989;452.
4. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Burkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 68:1994;4650.
5. Brodie S.J., Lewinsohn D.A., Patterson B.K., Jiyamapa D., Krieger J., Corey L., Greenberg P.D., Riddell S.R. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med. 5:1999;34.
6. Borrow P., Lewicki H., Wei X., et al. Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 2:1997;205.
7. Price D.A., Goulder P.J.R., Klenerman P., et al. Cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA. 94:1997;1890.
8. Koenig S., Conley A.J., Brewah Y.A., et al. Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med. 1:1995;330.
9. Gouldre P.J., Phillips R.E., Colbert R.A., et al. Late escape from and immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3:1997;212.
10. Ogg G.S., Jin X., Bonhoeffer S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103.
11. Musey L., Hughes J., Schacker T., Shea T., Corey L., McElrath M.J. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med. 337:1997;1267.
12. Pantaleo G., Menzo S., Vaccarezza M., et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med. 332:1995;209.
13. Cao Y., Qin L., Zhang L., Safrit J., Ho D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 332:1995;201.
14. Harrer T., Harrer E., Kalams S.A., et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol. 156:1996;2616.
15. Bryson Y.J., Pang S., Wei L.S., Dickover R., Diagne A., Chen I.S. Clearance of HIV infection in a perinatally infected infant. N Engl J Med. 332:1995;833.
16. Newell M.L., Dunn D., De Maria A., Ferrazin A., De Rossi A., Giaquinto C., Levy J., Alimenti A., Ehrnst A., Bohlin A.B., et al. Detection of virus in vertically exposed HIV-antibody-negative children. Lancet. 347:1996;213.
17. Roques P.A., Gras G., Parnet-Mathieu F., Mabondzo A.M., Dollfus C., Narwa R., Marce D., et al. Clearance of HIV infection in 12 perinatally infected children clinical, virological and immunological data . AIDS. 9:1995;F19.
18. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., Gotch F., Aryioshi K., Hallam N., Kroll J.S., Froebel K., McMichael A. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860.
19. De Maria A., Cirillo C., Moretta L. Occurrence of human immunodeficiency virus type I (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1 infected mothers. J Infect Dis. 170:1994;1296.
20. Lane H.C., Depper J.M., Greene W.C., Whalen G., Waldmann T.A., Fauci A.S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 313:1985;79.
21. Shearer G.M., Clerici M. Early T-helper cell defects in HIV infection. AIDS. 5:1991;245.
22. Wilson C.C., Brown R.C., Korber R.T., Wilkes B.M., Ruhl D.J., Sakamoto D., Kunstman K., Luzuriaga K., Hanson I.C., Widmayer S.M., Wiznia A., Clapp S., Ammann A., Koup R.A., Wolinsky S.M., Walker B.D. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission the ariel project for the prevention of transmission of HIV from mother to infant . J Virol. 73:1999;3975.
23. Pantaleo G., Koenig S., Baseler M., Lane H.C., Fauci A.S. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. J Immunol. 144:1990;1696.
24. Wolthers K.C., Bea G., Wisman A., Otto S.A., de Roda Husman A.M., Schaft N., de Wolf F., Goudsmit J., Coutinho R.A., van der Zee A.G., Meyaard L., Miedema F. T cell telomere length in HIV infection no evidence for increased CD4+ T cell turnover . Science. 274:1996;1543.
25. Effros R.B., Allsopp R., Chiu C.P., Hausner M.A., Hirji K., Wang L., Harley C.B., Villeponteau B., West M.D., Giorgi J.V. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10:1996;F17.
26. Dalod M., Sinet M., Deschemins J.C., Fiorentino S., Venet A., Guillet J.G. Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients. Eur J Immunol. 29:1999;38.
27. Trimble L.A., Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood. 91:1998;585.
28. Hellerstein M., Hanley M.B., Cesar D., Siler S., Papageorgopoulos C., Wieder E., Schmidt D., Hoh R., Neese R., Macallan D., Deeks S., McCune J.M. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nat Med. 5:1999;83.
29. Ljunggren H.G., Kärre K. In search of the "missing self". MHC molecules and NK cell recognition. Immunol Today. 11:1990;237.
30. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619.
31. Moretta L., Ciccone E., Moretta A., Höglund P., Oöhlen C., Kärre K. Allorecognition by NK cells nonself or no self? Immunol Today. 13:1992;300.
32. Valiante N.M., Lienert K., Shilling H.G., Smits B.J., Parham P. Killer cell receptor keeping pace with MHC class I evolution . Immunol Rev. 155:1997;155.
33. + NK cells by the the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 172:1990;1589.
34. Moretta A., Vitale M., Bottino C., Orengo A., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 178:1993;597.
35. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M.S., Vitale M., Bottino C., Moretta L., Moretta A., Long E.O. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains. Immunity. 2:1995;439.
36. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405.
37. Litwin V., Gumperz J.E., Parham P., Phillips J.H., Lanier L.L. NKB1 a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules . J Exp Med. 180:1994;537.
38. Vitale M., Sivori S., Pende D., Augugliaro R., Di Donato C., Amoroso A., Malnati M., Bottino C., Moretta L., Moretta A. Physical and functional independency of p70 and p58 natural killer (NK) cell receptor for HLA class I their role in the definition of different groups of alloreative NK cell clones . Proc Natl Acad Sci USA. 93:1996;1453.
39. Pende D., Biassoni R., Cantoni C., Verdiani S., Falco M., Di Donato C., Accame L., Bottino C., Moretta A., Moretta L. The natural killer cell receptor specific for HLA-A allotypes a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer . J Exp Med. 184:1996;505.
40. Doring C., Scheidegger D., Samaridis J., Cella M., Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol. 156:1996;3098.
41. Aramburu J., Balboa M.A., Ramirez A., Silva A., Acevedo A., Sánchez-Madrid F., de Landázuri M.O., Lòpez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol. 44:1990;3238.
42. Braud V.M., Allan D.S.J., O'Callaghan C.A., Sàderstràm K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer receptor CD94/NKG2A, B and C. Nature. 391:1998;795.
43. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lòpez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
44. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells structural evidence for new stimulatory and inhibitory pathways . Eur J Immunol. 21:1996;660.
45. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peters L., Hsu M. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules Immunity. 7:1997;273.
46. Cantoni C., Verdiani S., Falco M., Pessino A., Cilli M., Conte R., Pende D., Ponte M., Mikaelsson M.S., Moretta L., Biassoni R. p49, A putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980.
47. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor . Proc Natl Acad Sci USA. 96:1999;5674.
48. Ferrini S., Cambiaggi A., Meazza R., Sforzini R., Marciano S., Mingari M.C., Moretta L. T cell clones expressing the NK-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 24:1994;2294.
49. Mingari M.C., Vitale C., Cambiaggi A., Schiavetti F., Melioli G., Ferrini S., Poggi A. Cytolytic T lymphocytes displaying natural killer (NK)-like activity expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production . Int Immunol. 7:1995;697.
50. Phillips J.H., Gumperz J.E., Parham P., Lanier L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 268:1995;403.
51. Mingari M.C., Ponte M., Cantoni C., Vitale C., Schiavetti F., Bertone S., Bellomo R., Tradori-Cappai A., Biassoni R. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells . Int Immunol. 9:1997;485.
52. Mingari M.C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A.S., Moretta L. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell population. Proc Natl Acad Sci USA. 93:1996;12433.
53. Kagi D., Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol. 8:1996;472.
54. Ikeda H., Lethé B., Lehmann F., Van Baren N., Baurain J.F., De Smet C., Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 6:1997;199.
55. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M.C., Bassetti D., Fauci A.S., Moretta L. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes impairment of specific cytolytic functions . Proc Natl Acad Sci USA. 94:1997;10285.
56. Mingari M.C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F., Bertone S., Moretta A., Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor . Eur J Immunol. 27:1997;1374.
57. + T cells . Proc Natl Acad Sci USA. 95:1998;1172.
58. Bertone S., Schiavetti F., Bellomo R., Vitale C., Ponte M., Moretta L., Mingari M.C. Transforming growth factor-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol. 29:1999;23.
59. Meazza R., Gaggero A., Neglia F., Basso S., Sforzini S., Pereno R., Azzarone B., Ferrini S. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion role of different signal peptides . Eur J Immunol. 27:1997;1049.
60. López-Botet M., Bellón T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol. 11:1999;301.
61. Rasty S., Thatikunta P., Gordon J., Khalili K., Amini S., Glorioso J.C. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc Natl Acad Sci USA. 93:1996;6073.
62. Zauli G., Davis B.R., Re M.C., Visani G., Furlini G., La Placa M. Tat protein stimulates production of transforming growth factor beta1 by marrow macrophages a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression . Blood. 80:1992;3036.
63. Quaranta M.G., Camponeschi B., Straface E., Malorni W., Viora M. Induction of interleukin-15 production by HIV-1 nef protein a role in the proliferation of uninfected cells . Exp Cell Res. 250:1999;112.
64. Pantaleo G., De Maria A., Koenig S., Butini L., Moss B., Baseler M., Lane H.C., Fauci A.S. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci USA. 87:1990;4818.
65. Tsubota H., Ringler D.J., Kannagi M., King N.W., Solomon K.R., MacKey J.J., Walsh D.G., Letvin N.L. CD8+CD4- lymphocyte lines can harbor the AIDS virus. J Immunol. 143:1989;858.
66. De Maria A., Pantaleo G., Schnittman S.M., Greenhouse J.J., Baseler M., Orenstein J.M., Fauci A.S. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol. 146:1991;2220.
67. De Maria A., Colombini S., Schnittman S.M., Moretta L. CD8+ Cytolytic lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells. Eur J Immunol. 24:1994;531.
68. Livingstone WJ, Moore M, Innes D, Bell JE, Simmonds P: Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet 348:649, 1996.
69. Xu X.-N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., Baur A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med. 189:1999;1489.
70. Cauda R., Goletti D., Lucia M.B., Tumbarello M., Rumi C., Orengo A.M., Moretta A. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. Clin Immunol Immunopathol. 70:1994;198.
71. Andre P., Brunet C., Guia S., Gallais H., Sampol J., Vivier E., Dignat-George F. Differential regulation of killercell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1 infected individuals. Eur J Immunol. 29:1999;1076.
72. Gray CM, Lawrence J, Schapiro JM, et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 162:1780, 1999.
73. Cohen B.C., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661.